ENDPOINTS

Draig Therapeutics unveils $140M Series A for neuropsychiatry pipeline

A UK biotech named after the Welsh word for dragon has emerged from stealth with a Phase 2-ready candidate for depression and an oversubscribed Series A fundraise backed by the venture arm of Sanofi. ...

Jun 18, 2025 - 05:10
 0
Draig Therapeutics unveils $140M Series A for neuropsychiatry pipeline
A UK biotech named after the Welsh word for dragon has emerged from stealth with a Phase 2-ready candidate for depression and an oversubscribed Series A fundraise backed by the venture arm of Sanofi. ...
Read More

Tags:

Previous Article

Elon Musk’s A.I. Company Faces Lawsuit Over Gas-Burning Turbines

Next Article

AHIP CEO on the Budget Bill: “We Are Very Concerned About the Impact on Coverage”

Related Posts

#EHA25: Gilead, Arcellx continue to tout safety of multiple myeloma cell therapy anito-cel

#EHA25: Gilead, Arcellx continue to tout safety of mult...

Jun 16, 2025  0

Will the FDA approve Moderna's next-gen Covid shot?

Will the FDA approve Moderna's next-gen Covid shot?

May 28, 2025  0

Former a16z biotech investment leader Vijay Pande exits the VC firm

Former a16z biotech investment leader Vijay Pande exits...

Jun 10, 2025  0